Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...

Scientists analyzed almost 200 cannabis genomes to create the most comprehensive, high-quality, detailed genetic atlas of the plant to date. The atlas reveals unprecedented diversity and complexity ...

Traditional, Complementary, and Integrative Medicine (TCIM) is a significant resource for long-term health, recognized by the ...

The global sales of peptide therapeutics is estimated to be worth USD 42.1 billion in 2024 and anticipated to reach a value ...

Three times a week, Hank Van Parys, 94, heads to the YMCA in Kingston, N.Y., where he leads a cardiovascular fitness class. Van Parys joined the group back in 1980 when IBM, where he worked as a ...

According to the latest global university rankings, these ten universities excel in scholarship, innovation, and international collaboration. Whether you’re drawn to advances in technology, leadership ...

Precision Oncology market is set for strong growth through 2035, fueled by genomic advances, rising cancer cases, and increased use of targeted therapies.

PDS Biotechnology Corp (NASDAQ ... A: Dr. Kirk Shepard, Chief Medical Officer, explained that the KEYNOTE-689 trial primarily involved HPV negative patients, with only 3% to 4% being HPV positive.

WHITE BEAR LAKE, MN - Envoy Medical®, Inc. (NASDAQ: COCH), a medical device company with a market capitalization of $35.64 million, has announced a significant milestone in their clinical trial ...

The NevBio is an organization of institutes, companies, and academia in Nevada engaged in the fields of biotechnology, pharmaceutical research and production, medical devices, and health science ...